The online home for the primary care professionals managing patients with cardiovascular disease, diabetes and related diseases.

Understanding the incretin effect and GLP1 receptor agonist therapy

Understanding the incretin effect and GLP1 receptor agonist therapy

Publication date: Thursday, 03 June 2021
Contributor(s): Jane Diggle, Michael Cummings

The first of 3 interactive programmes providing practical answers about GLP-1 receptor agonist therapy. Jane Diggle and Mike Cummings discuss the practicalities of effectively initiating GLP-1 receptor agonists in daily practice.

Download the factsheet to this webinar below or watch the on-demand video here:
View the on-demand webinar

And don't forget to complete the CPD programme on our Sister site BJPCN to get your CPD points and download your certificate: 
Go to the CPD programme*

This educational programme has been sponsored by Eli Lilly and Company.

*Please note that registration is required. Simply register to create your free-of-charge personal account 

Sponsorship information:
This educational programme has been sponsored by Eli Lilly and Company
Topics covered:
Category: Webinars
Edition: Volume 1 Number 6 June-July 2021
Contributor(s): Jane Diggle, Michael Cummings

Article search and filter